Figures & data
Figure 1 PRISMA flowchart of study selection.
![Figure 1 PRISMA flowchart of study selection.](/cms/asset/ca3bb55e-48ab-40bc-a9c7-f71819afb9f1/dcop_a_12152716_f0001_c.jpg)
Table 1 Summary of Studies Characteristics
Table 2 Study Quality Assessment of Eligible Trials
Figure 2 Meta-analysis of experimental and control groups in SF-36 PCS.
![Figure 2 Meta-analysis of experimental and control groups in SF-36 PCS.](/cms/asset/50ac166c-c637-406c-9b56-a3634384a9fe/dcop_a_12152716_f0002_c.jpg)
Figure 3 Meta-analysis of experimental and control groups in SF-36 MCS.
![Figure 3 Meta-analysis of experimental and control groups in SF-36 MCS.](/cms/asset/72a0da43-2dab-4168-bb01-49a52744906d/dcop_a_12152716_f0003_c.jpg)
Figure 4 Meta-analysis of experimental and control groups in ISWT.
![Figure 4 Meta-analysis of experimental and control groups in ISWT.](/cms/asset/ccb4b61c-5a71-42f3-9119-e42f0040f301/dcop_a_12152716_f0004_c.jpg)
Figure 5 Meta-analysis of experimental and control groups in Hads-A.
![Figure 5 Meta-analysis of experimental and control groups in Hads-A.](/cms/asset/659fdcf7-fa03-4946-93f5-1b44ec80eec3/dcop_a_12152716_f0005_c.jpg)
Figure 6 Meta-analysis of experimental and control groups in Hads-D.
![Figure 6 Meta-analysis of experimental and control groups in Hads-D.](/cms/asset/05db0c8f-f97d-4cad-860c-6e39f4b10f9e/dcop_a_12152716_f0006_c.jpg)
Table 3 Acceptance, Completion and Drop-Out Rates